The metabolic hormone FGF21 is associated with endothelial dysfunction in hemodialysis patients.

Crina Claudia RusuSimona RacasanIna Maria KacsoDiana MoldovanAlina PotraDacian TirinescuCristian BudureaRemus OrasanIoan Mihai PatiuCosmina Ioana BondorDan VladutiuMirela Gherman Caprioara

Published in: International urology and nephrology (2016)

High FGF21 values in our patients are correlated with atherosclerosis risk factors: hypercholesterolemia, hypertriglyceridemia, hypertension, increased TST and increased levels of sTWEAK. Endothelial dysfunction is associated with high FGF21 in HD patients.

Keyphrases

end stage renal disease
ejection fraction
risk factors
newly diagnosed
chronic kidney disease
peritoneal dialysis
cardiovascular disease
prognostic factors
blood pressure
patient reported outcomes
coronary artery disease
cardiovascular events